Kaisa Luostari
Project Researcher
Institute of Clinical Medicine, School of Medicine, Faculty of Health Sciences
[email protected] | +358 40 355 3093
Publications
4/4 items-
Low expression levels of hepsin and TMPRSS3 are associated with poor breast cancer survival
Pelkonen Mikko, Luostari Kaisa, Tengström Maria, Ahonen Hermanni, Berdel Bozena, Kataja Vesa, Soini Ylermi, Kosma Veli-Matti, Mannermaa Arto, 2015, Bmc cancer, 15, 431. A1 Journal article (refereed), original research -
Overexpression of MicroRNA-200c Predicts Poor Outcome in Patients with PR-Negative Breast Cancer
Tuomarila M, Luostari K, Soini Y, Kataja V, Kosma VM, Mannermaa A, 2014, PLoS ONE, 9, 10, e109508: 1-8. A1 Journal article (refereed), original research -
Type II Transmembrane Serine Protease Gene Variants Associate with Breast Cancer
Luostari Kaisa, Hartikainen Jaana M, Tengström Maria, Palvimo Jorma J, Kataja Vesa, Mannermaa Arto, Kosma Veli-Matti, 2014, PLoS ONE, 9, 7, e102519. A1 Journal article (refereed), original research -
Proto-oncogene PIM-1 is a novel estrogen receptor target associating with high grade breast tumors
Malinen M, Jääskeläinen T, Pelkonen M, Heikkinen S, Väisänen S, Kosma VM, Nieminen K, Mannermaa A, Palvimo JJ, 2012, Molecular and cellular endocrinology, 2013; 365, 2, 270-276. A1 Journal article (refereed), original research